Quantcast

Latest Morphinans Stories

2014-06-12 12:28:55

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Moderate Pain - Pipeline Review, H1 2014 http://www.reportbuyer.com/pharma_healthcare/treatments/moderate_pain_pipeline_review_h1_2013.html Moderate Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, 'Moderate Pain - Pipeline Review, H1 2014', provides an overview of the Moderate Pain's therapeutic pipeline. This report provides comprehensive information on the therapeutic...

2014-06-11 23:00:39

Sunshine Summit Lodge, a Narconon drug rehabilitation program in California, has witnessed the trend of initial drug use change from illicit drugs over to prescription painkillers over the last decade. Because of recent news about the prescription epidemic, the facility is offering solutions through a new series of articles through it’s website, as well as effective treatment. (PRWEB) June 11, 2014 According to the CDC (The Center for Disease Control and Prevention), deaths from...

2014-06-11 12:26:03

President and CEO Mark A. Sirgo Describes BUNAVAIL(TM) Delivery, Competitive Advantages, Market Size and Patient Need RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding BUNAVAIL, BDSI's product for the maintenance treatment of opioid dependence that recently received approval from...

2014-06-10 08:29:27

RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34(th) Annual William Blair Growth Stock ConferenceWednesday, June 11, 20143:20 PM Central Time (4:20 PM Eastern Time)Four Seasons Hotel, Chicago, IL Wells Fargo 2014 Healthcare ConferenceTuesday, June 17, 20144:40 PM Eastern...

2014-06-09 16:25:50

Hundreds of Doctors to Gather to Develop Strategies to Reverse Rx Abuse Epidemic in New Jersey and Release of Parent Testimonial Video Featuring Four New Jersey Moms Whose Children Were Impacted by Rx Abuse and Heroin Abuse to be Released as Part of Week Long Activities. MILLBURN, N.J., June 9, 2014 /PRNewswire-USNewswire/ -- In commemoration of the first ever designation of June 9 -13, 2014 as Opioid Abuse Awareness Week, the Partnership for a Drug-Free New Jersey (PDFNJ) will be...

2014-06-06 23:01:39

TreatmentHelp helps debunk the claim that medication prescribed by a physician is always safer than illicit drugs. Delray Beach, FL (PRWEB) June 06, 2014 Prescription drugs have started to gain the notoriety of illicit drugs, especially among teenagers and individuals to whom the drugs were not prescribed. Taking prescription drugs without the supervision of a physician can be extremely dangerous and life-threatening to overall health and well-being. Some of the most commonly abused...

2014-06-06 23:01:17

A nasal-spray version of Naloxone, a heroin/opiate overdose-reversal drug, is in the works in Kentucky. (PRWEB) June 06, 2014 As reported by USA Today in the article Nasal Spray For Heroin Antidote Under Development(5/31), a Kentucky doctor has been successful in advocating a nasal spray medicine to reverse a heroin or opiate overdose. Dr. Daniel Wermeling has made a deal with a pharmaceutical company to create a nasal spray version of naloxone, a common medicine used on persons who are...

2014-06-06 16:24:14

First and Only FDA-Approved Buccal Film Formulation of Buprenorphine and Naloxone to Compete in the $1.7 Billion and Growing U.S. Opioid Dependence Market RALEIGH, N.C., June 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) received approval of the New Drug Application (NDA) for BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA). BUNAVAIL is indicated for the maintenance treatment of...

2014-06-05 13:33:09

University of Michigan Health System With naloxegol, adults found relief from opioid-induced constipation Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System. Globally, approximately 28 million to 35 million, or nearly half, of patients taking opioids for long-term pain develop constipation. Laxatives provide sub-optimal relief. The...

2014-06-05 12:29:48

CHICAGO, June 5, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) issued on March 14, 2014 revised guidance, "Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids". http://photos.prnewswire.com/prnvar/20131024/CG03341LOGO In an open letter to CMS discussing the guidance, the Physician-Patient Alliance for Health & Safety applauds CMS for this guidance as...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related